48-mer Synthetic peptide analogue of the hepatitis B virus 'a' determinant induces an anti-HBs antibody response after a single injection

Journal of Medical Virology

Volumn 62, Issue 2, 2000, Pages 159-166

  Moynihan, Jennifer S ^a   D'Mello, Felicity I M ^a   Howard, Colin R ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Hepatitis B virus; Synthetic peptides; Vaccines

Indexed keywords

ANTIGEN; EPITOPE; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B VACCINE; POLYSTYRENE;

AMINO ACID SYNTHESIS; ANTIBODY RESPONSE; ARTICLE; CROSS REACTION; HEPATITIS B; HEPATITIS B VIRUS; IMMUNE RESPONSE; PEPTIDE SYNTHESIS; PROTEIN CONFORMATION; SYNTHESIS;

ANIMALS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EPITOPES; GUINEA PIGS; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; IMMUNIZATION; MICE; MICE, INBRED BALB C; MOLECULAR MIMICRY; PEPTIDES;

CAVIA; DNA VIRUSES; HEPATITIS B VIRUS;

EID: 0033823111     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9071(200010)62:2<159::AID-JMV6>3.0.CO;2-X     Document Type: Article

References (21)

1. Altering the antigenicity of proteins
2. Protection against foot- and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence
3. Engineering of immunogenic peptides by co-linear synthesis of determinants recognized by B and T cells
4. Affinity of antibody responses in man to hepatitis B vaccine determined with synthetic peptides
5. Vaccine-induced escape mutant of hepatitis B virus
6. Nonresponders to hepatitis B vaccine can present envelope particles to T lymphocytes
7. The cellular basis for lack of antibody response to hepatitis B vaccine in humans
8. Breakthrough infections and identification of a viral variant in Gambian children immunized with hepatitis B vaccine
9. Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan
10. A novel hepatitis B virus variant in the sera of immunized children
11. A hepatitis B virus variant found in the sera of immunised children induces a conformational change in the HBsAg 'a' determinant
12. First peptide vaccine providing protection against viral infection in the target animal: Studies of canine parvovirus in dogs
13. Long-term immunogenicity and efficacy of hepatitis B vaccine in infants born to HBeAg-positive HBsAg-carrier mothers
14. Protection against morbillivirus-induced encephalitis by immunization with a rationally designed synthetic peptide containing B- and T-cell epitopes from the fusion protein of measles virus
15. Molecular epidemiology of hepatitis B virus vaccine variants in Singapore
16. Natural history of hepatitis B surface antigen mutants in children
17. Immune responses in mice following immunization with chimeric synthetic peptides representing B and T cell epitopes of measles virus proteins
18. Influence of protein-quaternary structure on antigen processing
19. Effect of variation in the common 'a' determinant on the antigenicity of hepatitis B surface antigen
20. A topological model for hepatitis B surface antigen
21. A surrogate hepatitis B virus antigenic epitope represented by a synthetic peptide and an internal image antiidiotype antibody